Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells

Neurochemistry International

Volumn 68, Issue 1, 2014, Pages 38-47

  Sato, Koichi ^a   Tobo, Masayuki ^a   Mogi, Chihiro ^a   Murata, Naoya ^a   Kotake, Mie ^a   Kuwabara, Atsushi ^b   Im, Dong Soon ^c   Okajima, Fumikazu ^a  

^a GUNMA UNIVERSITY   (Japan)

^b TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c Pusan National University   (South Korea)

Author keywords

High density lipoprotein; Lysophosphatidic acid; Neurite remodeling; Oxidation; PC12 cell; Sphingosine 1 phospahte

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; NERVE GROWTH FACTOR; OXIDIZED HIGH DENSITY LIPOPROTEIN; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; LYSOPHOSPHOLIPID;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DESENSITIZATION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MULTIPLE SCLEROSIS; NERVE FIBER GROWTH; NEURITE; NONHUMAN; OXIDATION; PC12 CELL; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; RNA ANALYSIS; ANIMAL; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PC12 CELL LINE;

ANIMALS; CELLS, CULTURED; HUMANS; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; NERVE GROWTH FACTORS; NEURITES; OXIDATION-REDUCTION; PC12 CELLS; RATS;

EID: 84896295943     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.02.005     Document Type: Article

References (48)

1. S. Arlt, U. Beisiegel, and A. Kontush Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease Curr. Opin. Lipidol. 13 2002 289 294 (Pubitemid 34592286)
2. Z. Balazs, U. Panzenboeck, A. Hammer, A. Sovic, O. Quehenberger, E. Malle, and W. Sattler Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model J. Neurochem. 89 2004 939 950 (Pubitemid 38684741)
3. J.E. Bottenstein, S.D. Skaper, S.S. Varon, and G.H. Sato Selective survival of neurons from chick embryo sensory ganglionic dissociates utilizing serum-free supplemented medium Exp. Cell Res. 125 1980 183 190 (Pubitemid 10140128)
4. S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M.W. Pfaffl, G.L. Shipley, J. Vandesompele, and C.T. Wittwer The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments Clin. Chem. 55 2009 611 622
5. J.W. Choi, and J. Chun Lysophospholipids and their receptors in the central nervous system Biochim. Biophys. Acta 1831 2013 20 32
6. A. Damirin, H. Tomura, M. Komachi, J.P. Liu, C. Mogi, M. Tobo, J.Q. Wang, T. Kimura, A. Kuwabara, Y. Yamazaki, H. Ohta, D.S. Im, K. Sato, and F. Okajima Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells Am. J. Physiol. Heart Circ. Physiol. 292 2007 H2513 H2522
7. G. Ferretti, and T. Bacchetti Peroxidation of lipoproteins in multiple sclerosis J. Neurol. Sci. 311 2011 92 97
8. A. Hall, and G. Lalli Rho and Ras GTPases in axon growth, guidance, and branching Cold Spring Harb. Perspect. Biol. 2 2010 a001818
9. Y. Ikeno, N. Konno, S.H. Cheon, A. Bolchi, S. Ottonello, K. Kitamoto, and M. Arioka Secretory phospholipases A2 induce neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor J. Biol. Chem. 280 2005 28044 28052 (Pubitemid 41076922)
10. I. Ishii, N. Fukushima, X. Ye, and J. Chun Lysophospholipid receptors: signaling and biology Annu. Rev. Biochem. 73 2004 321 354 (Pubitemid 39050372)
11. A.D. Kay, S.P. Day, M. Kerr, J.A. Nicoll, C.J. Packard, and M.J. Caslake Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury J. Neurotrauma 20 2003 717 723 (Pubitemid 36993447)
12. A.D. Kay, S.P. Day, J.A. Nicoll, C.J. Packard, and M.J. Caslake Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage Atherosclerosis 170 2003 141 146 (Pubitemid 37083572)
13. J.N. Keller, K.B. Hanni, and M.S. Kindy Oxidized high-density lipoprotein induces neuron death Exp. Neurol. 161 2000 621 630 (Pubitemid 30137019)
14. J.N. Keller, K.B. Hanni, and W.R. Markesbery Oxidized low-density lipoprotein induces neuronal death: implications for calcium, reactive oxygen species, and caspases J. Neurochem. 72 1999 2601 2609 (Pubitemid 29242213)
15. A. Khalil, H. Berrougui, G. Pawelec, and T. Fulop Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease Mech. Ageing Dev. 133 2012 20 29
16. T. Kimura, K. Sato, A. Kuwabara, H. Tomura, M. Ishiwara, I. Kobayashi, M. Ui, and F. Okajima Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells J. Biol. Chem. 276 2001 31780 31785
17. S.C. Kivatinitz, M.A. Pelsman, A.C. Alonso, L. Bagatolli, and S. Quiroga High-density lipoprotein aggregated by oxidation induces degeneration of neuronal cells J. Neurochem. 69 1997 2102 2114 (Pubitemid 27452758)
18. M. Komachi, K. Sato, M. Tobo, C. Mogi, T. Yamada, H. Ohta, H. Tomura, T. Kimura, D.S. Im, K. Yanagida, S. Ishii, I. Takeyoshi, and F. Okajima Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo Cancer Sci. 103 2012 1099 1104
19. A.J. MacLennan, B.K. Devlin, L. Marks, A.A. Gaskin, K.L. Neitzel, and N. Lee Antisense studies in PC12 cells suggest a role for H218, a sphingosine 1-phosphate receptor, in growth-factor-induced cell-cell interaction and neurite outgrowth Dev. Neurosci. 22 2000 283 295
20. E. Malchinkhuu, K. Sato, T. Muraki, K. Ishikawa, A. Kuwabara, and F. Okajima Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function Biochem. J. 370 2003 817 827 (Pubitemid 36399073)
21. H.F. McMurray, S. Parthasarathy, and D. Steinberg Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes J. Clin. Invest. 92 1993 1004 1008 (Pubitemid 23262425)
22. W.H. Moolenaar Bioactive lysophospholipids and their G protein-coupled receptors Exp. Cell Res. 253 1999 230 238
23. N. Murata, K. Sato, J. Kon, H. Tomura, M. Yanagita, A. Kuwabara, M. Ui, and F. Okajima Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions Biochem. J. 352 Pt 3 2000 809 815 (Pubitemid 32015038)
24. M. Navab, S.T. Reddy, B.J. Van Lenten, G.M. Anantharamaiah, and A.M. Fogelman The role of dysfunctional HDL in atherosclerosis J. Lipid Res. 50 Suppl. 2009 S145 S149
25. M. Navab, S.T. Reddy, B.J. Van Lenten, and A.M. Fogelman HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms Nat. Rev. Cardiol. 8 2011 222 232
26. J.R. Nofer, M. Fobker, G. Hobbel, R. Voss, I. Wolinska, M. Tepel, W. Zidek, R. Junker, U. Seedorf, A. von Eckardstein, G. Assmann, and M. Walter Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux Biochemistry 39 2000 15199 15207
27. H. Ohta, K. Sato, N. Murata, A. Damirin, E. Malchinkhuu, J. Kon, T. Kimura, M. Tobo, Y. Yamazaki, T. Watanabe, M. Yagi, M. Sato, R. Suzuki, H. Murooka, T. Sakai, T. Nishitoba, D.S. Im, H. Nochi, K. Tamoto, H. Tomura, and F. Okajima Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors Mol. Pharmacol. 64 2003 994 1005 (Pubitemid 37153068)
28. F. Okajima Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim. Biophys. Acta 1582 2002 132 137 (Pubitemid 34634121)
29. F. Okajima, K. Sato, and T. Kimura Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I Endocr. J. 56 2009 317 334
30. A. Otocka-Kmiecik, D.P. Mikhailidis, S.J. Nicholls, M. Davidson, J. Rysz, and M. Banach Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog. Lipid Res. 51 2012 314 324
31. E. Perez-Gracia, R. Blanco, M. Carmona, E. Carro, and I. Ferrer Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease Acta Neuropathol. 118 2009 497 504
32. F.W. Pfrieger, and N. Ungerer Cholesterol metabolism in neurons and astrocytes Prog. Lipid Res. 50 2011 357 371
33. R. Salvayre, N. Auge, H. Benoist, and A. Negre-Salvayre Oxidized low-density lipoprotein-induced apoptosis Biochim. Biophys. Acta 1585 2002 213 221 (Pubitemid 36092085)
34. K. Sato, E. Malchinkhuu, Y. Horiuchi, C. Mogi, H. Tomura, M. Tosaka, Y. Yoshimoto, A. Kuwabara, and F. Okajima HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate Biochem. Biophys. Res. Commun. 359 2007 649 654 (Pubitemid 46899000)
35. K. Sato, E. Malchinkhuu, T. Muraki, K. Ishikawa, K. Hayashi, M. Tosaka, A. Mochiduki, K. Inoue, H. Tomura, C. Mogi, H. Nochi, K. Tamoto, and F. Okajima Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources J. Neurochem. 92 2005 904 914 (Pubitemid 40229563)
36. K. Sato, and F. Okajima Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein World J. Biol. Chem. 1 2010 327 337
37. K. Sato, H. Tomura, Y. Igarashi, M. Ui, and F. Okajima Exogenous sphingosine 1-phosphate induces neurite retraction possibly through a cell surface receptor in PC12 cells Biochem. Biophys. Res. Commun. 240 1997 329 334
38. K. Sattler, and B. Levkau Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection Cardiovasc. Res. 82 2009 201 211
39. C.L. Sayas, J. Avila, and F. Wandosell Regulation of neuronal cytoskeleton by lysophosphatidic acid: role of GSK-3 Biochim. Biophys. Acta 1582 2002 144 153 (Pubitemid 34634123)
40. T.L. Spires, and B.T. Hyman Neuronal structure is altered by amyloid plaques Rev. Neurosci. 15 2004 267 278 (Pubitemid 39388337)
41. J.R. Sundaram, E.S. Chan, C.P. Poore, T.K. Pareek, W.F. Cheong, G. Shui, N. Tang, C.M. Low, M.R. Wenk, and S. Kesavapany Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration J. Neurosci. 32 2012 1020 1034
42. 2+ signaling and Rho J. Neurochem. 66 1996 537 548
43. G. Tigyi, and R. Miledi Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells J. Biol. Chem. 267 1992 21360 21367
44. R.E. Toman, S.G. Payne, K.R. Watterson, M. Maceyka, N.H. Lee, S. Milstien, J.W. Bigbee, and S. Spiegel Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension J. Cell Biol. 166 2004 381 392 (Pubitemid 39031241)
45. J.E. Vance, and H. Hayashi Formation and function of apolipoprotein E-containing lipoproteins in the nervous system Biochim. Biophys. Acta 1801 2010 806 818
46. K.H. Weisgraber, and R.W. Mahley Human apolipoprotein E: the Alzheimer's disease connection FASEB J. 10 1996 1485 1494 (Pubitemid 26384445)
47. T. Yamada, K. Sato, M. Komachi, E. Malchinkhuu, M. Tobo, T. Kimura, A. Kuwabara, Y. Yanagita, T. Ikeya, Y. Tanahashi, T. Ogawa, S. Ohwada, Y. Morishita, H. Ohta, D.S. Im, K. Tamoto, H. Tomura, and F. Okajima Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1 J. Biol. Chem. 279 2004 6595 6605 (Pubitemid 38248796)
48. D.H. Yun, E.S. Jeon, S.M. Sung, S.H. Ryu, and J.H. Kim Lysophosphatidylcholine suppresses apoptosis and induces neurite outgrowth in PC12 cells through activation of phospholipase D2 Exp. Mol. Med. 38 2006 375 384 (Pubitemid 44390515)